TP53 and renal cell carcinoma: TRIM47 increases p53 ubiquitination and degradation by interacting with p53 protein, thus promoting the malignant biological behavior of renal cell carcinoma (Table 1) (Supplementary Table S1) (Chen et al., 2021).